Company / CapEx per Share
BioMarin Pharmaceutical CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.54
FY2025
5-year range
$0.45 / $0.65
FY2021-FY2025
Trend
+19.7%
vs FY2024
Sector context
#24 of 192
Health Care
What the data says
BioMarin Pharmaceutical's capex per share of $0.54 is higher than 88% of companies in the Health Care sector (FY2025). CapEx per Share returned to growth in FY2025 after 2 years of decline, reaching $0.54.
Based on SEC 10-K filings.
0.54 in FY2025 with a 5-year CAGR of -3.2%. Top quartile in the Health Care sector.
Improved from $0.51 to $0.54 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -6.2%
- 5-Year CAGR
- -3.2%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 192This company $0.54 Sector average $3.54
▼
-84.9% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 19.7% year-over-year.
- Ranks #24 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2017.
- Lowest capex per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.54 | +19.7% |
| FY2024 | $0.45 | -12.7% |
| FY2023 | $0.51 | -21.1% |
| FY2022 | $0.65 | +23.5% |
| FY2021 | $0.53 | -16.4% |
| FY2020 | $0.63 | -22.0% |
| FY2019 | $0.81 | -0.6% |
| FY2018 | $0.81 | -28.4% |
| FY2017 | $1.13 | +31.8% |
| FY2016 | $0.86 | -39.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026